Blog

Today, the FDA is meeting with its obstetric and gynecologic medical devices “advisory committee” to “help” the Agency decide the fate of surgical mesh devices commonly used in pelvic surgery on women, including procedures to remedy vaginal prolapse and urinary incontinence. The committee is supposed to be a group of outside “experts,” including a…

The popular osteoporosis medication Fosamax (alendronate sodium) has been linked to osteonecrosis of the Jaw (ONJ), femur fractures, and severe musculoskeletal pain. If you or a loved one has been injured by Fosamax, you should contact our lawyers immediately for a free confidential case evaluation. You may be entitled to compensation for your injuries…

A panel of U.S. Food and Drug Administration (FDA) advisors has convened in Gaithersburg, MD to discuss the future of transvaginal mesh products. The meeting was called after an influx of adverse events, regarding the surgical application of transvaginal mesh, had been reported in recent years. According to officials at the FDA, the meeting…

There have been numerous cases where patients have experienced failures involving Zimmer Durom hip replacement cups. It is believed by some that the company marketed the device knowing that it was defective and would result in a high rate of failure. If you or a loved one has been injured by a defective Zimmer…

September 13, 2011 witnessed two American advocacy groups attempt to hold the pope and the Vatican accountable in an international court, for what many are calling crimes against humanity. On Tuesday, the Center for Constitutional Rights and the Survivors Network of those Abused by Priests filed a complaint aimed directly at the Vatican. The…

According to federal health officials, a multi-state Salmonella outbreak continues to threaten states on the east coast. However, related cases of Salmonella poisoning have spread as far west as Texas. To date, the current outbreak has affected a total of 93 people in 19 separate states. While investigations by both the Centers for Disease…

On September 22, 2011, the European Medicines Agency (EMA) implemented stricter regulations on the already popular heart-rhythm drug Multaq. According to the EMA, there is “an increased risk of Multaq causing injury to the liver as well as the lungs when used in accordance with the currently approved prescribing information.” Subsequently, the U.S. Food…

On February 17, 2011 the U.S. Food & Drug Administration (FDA) added a “Black Box Warning” to Terbutaline. Terbutaline injections or infusion pump transmission has been linked to an increased risk of serious, life-threatening side effects including heart problems and death to fetus, neonate, and/or mother when administered to pregnant women. If you or…